J. Cortes
Vall d'Hebron University Hospital/ Vall d'Hebron Institute of Oncology
27 papers found
Refreshing results…
PI3K activation promotes resistance to eribulin in HER2-negative breast cancer
Uploadp95HER2–T cell bispecific antibody for breast cancer treatment
UploadMissing publications? Search for publications with a matching author name.